James M. Inhofe sold Editas Medicine Inc (NASDAQ: EDIT)
James M. Inhofe (R-OK), a U.S. Senator, has disclosed 2 trades in Editas Medicine Inc (EDIT) since 2017, 1 purchase and 1 sale, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James M. Inhofe sold $15,001 - $50,000 of Editas Medicine Inc (NASDAQ: EDIT) on February 4, 2019. Since that trade, EDIT is down -88.13% against the S&P 500 up +199.07%, an outperformance of -287.20%.
Across these filings, James M. Inhofe has been a balanced trader of EDIT (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James M. Inhofe's EDIT trades vs the price
EDIT is down -88.13% since James M. Inhofe sold on February 4, 2019, versus +199.07% for the S&P 500.
Performance since this trade
All James M. Inhofe EDIT trades
James M. Inhofe & EDIT trading FAQ
Is it legal for James M. Inhofe to trade Editas Medicine Inc (EDIT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Editas Medicine Inc (EDIT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James M. Inhofe sell EDIT?
James M. Inhofe disclosed a sale of $15,001 - $50,000 of Editas Medicine Inc (EDIT) on February 4, 2019, according to public STOCK Act filings.
How has EDIT performed since James M. Inhofe's trade?
Since James M. Inhofe sold EDIT on February 4, 2019, the stock is down -88.13%, versus +199.07% for the S&P 500 over the same period, an outperformance of -287.20%.
How many times has James M. Inhofe traded EDIT?
James M. Inhofe has disclosed 2 EDIT trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional EDIT trades?
Quantellect tracks every disclosed congressional trade in Editas Medicine Inc (EDIT) on the Editas Medicine Inc congressional trading page, which aggregates filings across all members of Congress.
James M. Inhofe's EDIT tradesAll congressional filings for Editas Medicine IncJames M. Inhofe's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.